KEYMAKER-U02: Investigational agents with or without pembrolizumab or pembrolizumab alone in melanoma Meeting Abstract


Authors: Long, G. V.; Dummer, R.; Pavlick, A. C.; Postow, M. A.; Ribas, A.; Robert, C.; Scolyer, R. A.; Taube, J. M.; Tetzlaff, M.; Su, S. C.; Singh, R.; Diede, S. J.; Tawbi, H. A. H.
Abstract Title: KEYMAKER-U02: Investigational agents with or without pembrolizumab or pembrolizumab alone in melanoma
Meeting Title: 48th Annual Scientific Meeting of the Clinical Oncology Society of Australia (COSA)
Journal Title: Asia-Pacific Journal of Clinical Oncology
Volume: 17
Issue: Suppl. 9
Meeting Dates: 2021 Nov 16-18
Meeting Location: Virtual
ISSN: 1743-7555
Publisher: Wiley Blackwell  
Date Published: 2021-11-01
Start Page: 202
Language: English
ACCESSION: WOS:000717281500340
PROVIDER: wos
PUBMED: 34766444
DOI: 10.1111/ajco.13716
Notes: Meeting Abstract: 399 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Michael Andrew Postow
    362 Postow